404 results
Page 4 of 21
8-K
EX-10.2
ny48g0t05ysz2 7k7
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
8-K
EX-10.1
qs5fk wav2onus
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
424B3
a8lx1u
29 Jun 20
Prospectus supplement
12:00am
424B5
5njds7em1sadxl 5g
26 May 20
Prospectus supplement for primary offering
4:02pm
8-K
EX-10.1
ja59f yshaf4
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
8-K
EX-10.2
ug481 i9ly4hvswa
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
8-K
EX-4.1
7cln1knys56em
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
424B5
eif8qlu sc1ic76br
27 Apr 20
Prospectus supplement for primary offering
7:30am
8-K
EX-10.1
xivripiq
24 Apr 20
Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:02pm
8-K
EX-10.2
07z02lp
24 Apr 20
Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:02pm
8-K
EX-4.1
7k6ta6sybryf2 eq1gf
24 Apr 20
Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:02pm
424B5
8gegzzsb2b37jam
20 Mar 19
Prospectus supplement for primary offering
5:19pm
424B5
avjyk3 oy
14 Mar 19
Prospectus supplement for primary offering
4:23pm